Table of Contents Author Guidelines Submit a Manuscript
BioMed Research International
Volume 2014, Article ID 937568, 9 pages
http://dx.doi.org/10.1155/2014/937568
Research Article

Ceftriaxone, a Beta-Lactam Antibiotic, Modulates Apoptosis Pathways and Oxidative Stress in a Rat Model of Neuropathic Pain

1Department of Pharmacology and Physiology, Faculty of Medicine, Sabzevar University of Medical Sciences, Sabzevar, Iran
2Department of Pharmacology, Pharmaceutical Sciences Research Center, School of Pharmacy, Isfahan University of Medical Sciences, Isfahan, Iran
3Department of Biotechnology, Pharmaceutical Research Center, School of Pharmacy, Mashhad University of Medical Sciences, Mashhad, Iran
4Pharmaceutical Research Center, Pharmacodynamy and Toxicology Department, School of Pharmacy, Mashhad University of Medical Sciences, P.O. Box 1365-91775, Vakilabad Boulevard, Mashhad, Iran

Received 23 February 2014; Revised 13 May 2014; Accepted 13 May 2014; Published 16 June 2014

Academic Editor: Livio Luongo

Copyright © 2014 Bahareh Amin et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. M. Zimmermann, “Pathobiology of neuropathic pain,” European Journal of Pharmacology, vol. 429, no. 1–3, pp. 23–37, 2001. View at Publisher · View at Google Scholar · View at Scopus
  2. M. Osikowicz, J. Mika, and B. Przewlocka, “The glutamatergic system as a target for neuropathic pain relief,” Experimental Physiology, vol. 98, no. 2, pp. 372–384, 2013. View at Publisher · View at Google Scholar · View at Scopus
  3. V. de Novellis, D. Siniscalco, U. Galderisi et al., “Blockade of glutamate mGlu5 receptors in a rat model of neuropathic pain prevents early over-expression of pro-apoptotic genes and morphological changes in dorsal horn lamina II,” Neuropharmacology, vol. 46, no. 4, pp. 468–479, 2004. View at Publisher · View at Google Scholar · View at Scopus
  4. S. Afrazi, S. Esmaeili-Mahani, V. Sheibani, and M. Abbasnejad, “Neurosteroid allopregnanolone attenuates high glucose-induced apoptosis and prevents experimental diabetic neuropathic pain: in vitro and in vivo studies,” The Journal of Steroid Biochemistry and Molecular Biology, vol. 139, pp. 98–103, 2014. View at Publisher · View at Google Scholar
  5. D. Varija, K. P. Kumar, K. P. Reddy, and V. K. Reddy, “Prolonged constriction of sciatic nerve affecting oxidative stressors & antioxidant enzymes in rat,” Indian Journal of Medical Research, vol. 129, no. 5, pp. 587–592, 2009. View at Google Scholar · View at Scopus
  6. N. N. Pathak, V. Balaganur, M. C. Lingaraju et al., “Atorvastatin attenuates neuropathic pain in rat neuropathy model by down-regulating oxidative damage at peripheral, spinal and supraspinal levels,” Neurochemistry International, vol. 68, pp. 1–9, 2014. View at Publisher · View at Google Scholar
  7. K. Chu, S.-T. Lee, D.-I. Sinn et al., “Pharmacological induction of ischemic tolerance by glutamate transporter-1 (EAAT2) upregulation,” Stroke, vol. 38, no. 1, pp. 177–182, 2007. View at Publisher · View at Google Scholar · View at Scopus
  8. P. Yogeeswari, A. Semwal, R. Mishra, and D. Sriram, “Current approaches with the glutamatergic system as targets in the treatment of neuropathic pain,” Expert Opinion on Therapeutic Targets, vol. 13, no. 8, pp. 925–943, 2009. View at Publisher · View at Google Scholar · View at Scopus
  9. B. Sung, G. Lim, and J. Mao, “Altered expression and uptake activity of spinal glutamate transporters after nerve injury contribute to the pathogenesis of neuropathic pain in rats,” Journal of Neuroscience, vol. 23, no. 7, pp. 2899–2910, 2003. View at Google Scholar · View at Scopus
  10. P. H. Chandrasekar, K. V. I. Rolston, B. R. Smith, and J. L. LeFrock, “Diffusion of ceftriaxone into the cerebrospinal fluid of adults,” Journal of Antimicrobial Chemotherapy, vol. 14, no. 4, pp. 427–430, 1984. View at Google Scholar · View at Scopus
  11. J. D. Rothstein, S. Patel, M. R. Regan et al., “β-Lactam antibiotics offer neuroprotection by increasing glutamate transporter expression,” Nature, vol. 433, no. 7021, pp. 73–77, 2005. View at Publisher · View at Google Scholar · View at Scopus
  12. C. Thöne-Reineke, C. Neumann, P. Namsolleck et al., “The β-lactam antibiotic, ceftriaxone, dramatically improves survival, increases glutamate uptake and induces neurotrophins in stroke,” Journal of Hypertension, vol. 26, no. 12, pp. 2426–2435, 2008. View at Publisher · View at Google Scholar · View at Scopus
  13. A. V. Jelenkovic, M. D. Jovanovic, D. D. Stanimirovic, D. D. Bokonjic, G. G. Ocic, and B. S. Boskovic, “Beneficial effects of ceftriaxone against pentylenetetrazole-evoked convulsions,” Experimental Biology and Medicine, vol. 233, no. 11, pp. 1389–1394, 2008. View at Publisher · View at Google Scholar · View at Scopus
  14. V. Hajhashemi, H. Hosseinzadeh, and B. Amin, “Antiallodynia and antihyperalgesia effects of ceftriaxone in treatment of chronic neuropathic pain in rats,” Acta Neuropsychiatrica, vol. 25, no. 1, pp. 27–32, 2013. View at Publisher · View at Google Scholar · View at Scopus
  15. Y. Hu, W. Li, L. Lu et al., “An anti-nociceptive role for ceftriaxone in chronic neuropathic pain in rats,” Pain, vol. 148, no. 2, pp. 284–301, 2010. View at Publisher · View at Google Scholar · View at Scopus
  16. E. K. Joseph and J. D. Levine, “Caspase signalling in neuropathic and inflammatory pain in the rat,” European Journal of Neuroscience, vol. 20, no. 11, pp. 2896–2902, 2004. View at Publisher · View at Google Scholar · View at Scopus
  17. M. Uchiyama and M. Mihara, “Determination of malonaldehyde precursor in tissues by thiobarbituric acid test,” Analytical Biochemistry, vol. 86, no. 1, pp. 271–278, 1978. View at Google Scholar · View at Scopus
  18. R. Dringen, “Metabolism and functions of glutathione in brain,” Progress in Neurobiology, vol. 62, no. 6, pp. 649–671, 2000. View at Publisher · View at Google Scholar · View at Scopus
  19. J. Tannenbaum, “Ethics and pain research in animals,” ILAR Journal, vol. 40, no. 3, pp. 97–110, 1999. View at Google Scholar · View at Scopus
  20. G. J. Bennett and Y.-K. Xie, “A peripheral mononeuropathy in rat that produces disorders of pain sensation like those seen in man,” Pain, vol. 33, no. 1, pp. 87–107, 1988. View at Google Scholar · View at Scopus
  21. M. M. Bradford, “A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein dye binding,” Analytical Biochemistry, vol. 72, no. 1-2, pp. 248–254, 1976. View at Google Scholar · View at Scopus
  22. M. Uchiyama and M. Mihara, “Determination of malonaldehyde precursor in tissues by thiobarbituric acid test,” Analytical Biochemistry, vol. 86, no. 1, pp. 271–278, 1978. View at Google Scholar · View at Scopus
  23. S. Maione, D. Siniscalco, U. Galderisi et al., “Apoptotic genes expression in the lumbar dorsal horn in a model neuropathic pain in rat,” NeuroReport, vol. 13, no. 1, pp. 101–106, 2002. View at Google Scholar · View at Scopus
  24. F. Wu, X. Miao, J. Chen et al., “Down-regulation of GAP-43 by inhibition of caspases-3 in a rat model of neuropathic pain,” International Journal of Clinical and Experimental Pathology, vol. 5, no. 9, pp. 948–955, 2012. View at Google Scholar · View at Scopus
  25. B. Costa, D. Siniscalco, A. E. Trovato et al., “AM404, an inhibitor of anandamide uptake, prevents pain behaviour and modulates cytokine and apoptotic pathways in a rat model of neuropathic pain,” British Journal of Pharmacology, vol. 148, no. 7, pp. 1022–1032, 2006. View at Publisher · View at Google Scholar · View at Scopus
  26. D. Siniscalco, C. Giordano, C. Fuccio et al., “Involvement of subtype 1 metabotropic glutamate receptors in apoptosis and caspase-7 over-expression in spinal cord of neuropathic rats,” Pharmacological Research, vol. 57, no. 3, pp. 223–233, 2008. View at Publisher · View at Google Scholar · View at Scopus
  27. A. C. S. Rezende, A. S. Vieira, F. Rogério et al., “Effects of systemic administration of ciliary neurotrophic factor on Bax and Bcl-2 proteins in the lumbar spinal cord of neonatal rats after sciatic nerve transection,” Brazilian Journal of Medical and Biological Research, vol. 41, no. 11, pp. 1024–1028, 2008. View at Google Scholar · View at Scopus
  28. D. Siniscalco, C. Fuccio, C. Giordano et al., “Role of reactive oxygen species and spinal cord apoptotic genes in the development of neuropathic pain,” Pharmacological Research, vol. 55, no. 2, pp. 158–166, 2007. View at Publisher · View at Google Scholar · View at Scopus
  29. C. F. Pereira and C. R. D. Oliveira, “Oxidative glutamate toxicity involves mitochondrial dysfunction and perturbation of intracellular Ca2+ homeostasis,” Neuroscience Research, vol. 37, no. 3, pp. 227–236, 2000. View at Publisher · View at Google Scholar · View at Scopus
  30. A.-C. Rimaniol, P. Mialocq, P. Clayette, D. Dormont, and G. Gras, “Role of glutamate transporters in the regulation of glutathione levels in human macrophages,” American Journal of Physiology: Cell Physiology, vol. 281, no. 6, pp. C1964–C1970, 2001. View at Google Scholar · View at Scopus
  31. Y. Sari, M. Sakai, J. M. Weedman, G. V. Rebec, and R. L. Bell, “Ceftriaxone, a beta-lactam antibiotic, reduces ethanol consumption in alcohol-preferring rats,” Alcohol and Alcoholism, vol. 46, no. 3, pp. 239–246, 2011. View at Publisher · View at Google Scholar · View at Scopus
  32. J. Lewerenz, P. Albrecht, M.-L. T. Tien et al., “Induction of Nrf2 and xCT are involved in the action of the neuroprotective antibiotic ceftriaxone in vitro,” Journal of Neurochemistry, vol. 111, no. 2, pp. 332–343, 2009. View at Publisher · View at Google Scholar · View at Scopus
  33. K. Chu, S.-T. Lee, D.-I. Sinn et al., “Pharmacological induction of ischemic tolerance by glutamate transporter-1 (EAAT2) upregulation,” Stroke, vol. 38, no. 1, pp. 177–182, 2007. View at Publisher · View at Google Scholar · View at Scopus
  34. K. M. Ramos, M. T. Lewis, K. N. Morgan et al., “Spinal upregulation of glutamate transporter GLT-1 by ceftriaxone: therapeutic efficacy in a range of experimental nervous system disorders,” Neuroscience, vol. 169, no. 4, pp. 1888–1900, 2010. View at Publisher · View at Google Scholar · View at Scopus
  35. A. MacAluso, M. Bernabucci, A. Trabucco et al., “Analgesic effect of a single preoperative dose of the antibiotic ceftriaxone in humans,” Journal of Pain, vol. 14, no. 6, pp. 604–612, 2013. View at Publisher · View at Google Scholar · View at Scopus